Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-027008
Filing Date
2019-12-26
Accepted
2019-12-26 16:31:33
Documents
1
Period of Report
2019-12-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 5352
  Complete submission text file 0001213900-19-027008.txt   6862
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Issuer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2655 MARSTON DRIVE ANCHORAGE AK 99517
Business Address
Rubini Jonathan Brian (Reporting) CIK: 0001723667 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52545 | Film No.: 191310857